Loading...
8 Germany Endocrinology Drugs Reports
Country Covered: Germany
Study Period: 2019 - 2029
Major Players: AbbVie Inc, AstraZeneca Plc, Novartis AG, Novo Nordisk A/S, Eli Lilly and Company
Country Covered: Germany
Study Period: 2019 - 2029
Major Players: Abbott Laboratories Inc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd, Endo International, Ferring Pharmaceuticals
Country Covered: Germany
Study Period: 2019 - 2029
Major Players: Abbvie Inc., Merck KGaA, Pfizer Inc., Exelixis Inc., Viatris Inc.
Country Covered: Germany
Study Period: 2019 - 2029
Major Players: Endo International Plc, AbbVie Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Allergan Plc
Country Covered: Germany
Study Period: 2019 - 2029
Major Players: Lannett Company, Inc, Horizon Therapeutics plc, Takeda Pharmaceutical Company Ltd, GlaxoSmithKline Plc, Regeneron Pharmaceuticals, Inc.
Country Covered: Germany
Study Period: 2019 - 2029
Major Players: Pfizer Inc, Ipsen, Chiasma, Inc, Validus Pharmaceuticals LLC, Novartis AG
Country Covered: Germany
Study Period: 2019 - 2029
Major Players: Pfizer, Inc, Novartis AG, Astrazeneca Plc, Merck & Co., Inc, Sun Pharma
Country Covered: Germany
Study Period: 2021 - 2029
Major Players: Sanzyme, Merck & Co. Inc., Ferring BV, Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd